SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes inspection of Ajanta Pharma’s facility at Gujarat

27 Jul 2018 Evaluate

US Food and Drug Administration (USFDA) has completed inspection of Ajanta Pharma’s formulation facility at Dahej in the state of Gujarat from July 23-27, 2018. After the inspection, there were no observations found.

Ajanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.


Ajanta Pharma Share Price

2800.25 10.10 (0.36%)
20-Apr-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1676.05
Dr. Reddys Lab 1237.50
Cipla 1239.40
Zydus Lifesciences 942.20
Lupin 2327.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×